Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An anomaly of bile acid synthesis characterized by mild cholestatic liver disease, fat malabsorption and/or neurological disease.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 7 | Fat malabsorption, Hepatic failure, Enlarged liver (hepatomegaly) |
Lab test results | 3 | Elevated circulating aspartate aminotransferase concentration, Hyperbilirubinemia, Elevated circulating hepatic transaminase concentration |
Growth and development | 1 | Failure to thrive |
Pregnancy and birth | 1 | Prolonged neonatal jaundice |
AMACR encodes alpha-methylacyl-CoA racemase (382 aa). Catalyzes the interconversion of (R)- and (S)-stereoisomers of alpha-methyl-branched-chain fatty acyl-CoA esters. Highest expression in Kidney Medulla (40.8 TPM) and Kidney Cortex (35.6 TPM).
Congenital bile acid synthesis defect 4 is associated with mutations in the AMACR gene on chromosome 5.
The AMACR protein participates in Isomerization of (2R)-pristanoyl-CoA to (2S)-pristanoyl-CoA pathway.
AMACR is classified as a druggable target (Enzyme category) with score 2.2.
Genetic testing for AMACR is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for congenital bile acid synthesis defect 4 has been reported in the published literature.
Phenotype severity distribution: 10 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for congenital bile acid synthesis defect 4.
11 publications have been identified in PubMed for congenital bile acid synthesis defect 4. Research spans Case Report / Case Series (64%), Review / Meta-Analysis (18%), and Diagnostic / Biomarker (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 64% |
Research summaries | 2 | 18% |
Testing and diagnosis research | 1 | 9% |
Clinical study results | 1 | 9% |
Hudson J (2026). [PMID: 41387259](https://pubmed.ncbi.nlm.nih.gov/41387259/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Lipiński P (2026). [PMID: 41766008](https://pubmed.ncbi.nlm.nih.gov/41766008/). *Journal of applied genetics*. [Review / Meta-Analysis]
Polak Y (2025). [PMID: 40643170](https://pubmed.ncbi.nlm.nih.gov/40643170/). *Journal of inherited metabolic disease*. [Clinical Trial Publication]
Wu LN (2025). [PMID: 40974585](https://pubmed.ncbi.nlm.nih.gov/40974585/). *The American journal of case reports*. [Case Report / Case Series]
Alsaleem BM (2025). [PMID: 39897470](https://pubmed.ncbi.nlm.nih.gov/39897470/). *Molecular genetics and metabolism reports*. [Case Report / Case Series]
Thio J (2025). [PMID: 40967667](https://pubmed.ncbi.nlm.nih.gov/40967667/). *BMJ case reports*. [Case Report / Case Series]
Palacio-Montoya MI (2024). [PMID: 37452652](https://pubmed.ncbi.nlm.nih.gov/37452652/). *The neuroradiology journal*. [Case Report / Case Series]
Wang CH (2024). [PMID: 39192447](https://pubmed.ncbi.nlm.nih.gov/39192447/). *Zhonghua er ke za zhi = Chinese journal of pediatrics*. [Review / Meta-Analysis]
Zhang W (2024). [PMID: 39584149](https://pubmed.ncbi.nlm.nih.gov/39584149/). *Journal of mass spectrometry and advances in the clinical lab*. [Diagnostic / Biomarker]
Selamioğlu A (2024). [PMID: 39544692](https://pubmed.ncbi.nlm.nih.gov/39544692/). *JIMD reports*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 12:45 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about congenital bile acid synthesis defect 4